Anya Borissova reviews a French trial that claims to be evidence that “ketamine is rapid, safe in the short term, and has persistent benefits for acute care in suicidal patients”.[read the full story...]
How could MDMA-assisted and psilocybin-assisted psychotherapy help people with depression and PTSD?
Anya Borissova and Philip Brooks consider a recent review exploring MDMA-assisted psychotherapy and psilocybin-assisted psychotherapy for trauma-related mental health difficulties.[read the full story...]
Ketamine “shows promise” as an anti-suicidal ideation agent, but will this promise ever be realised?
Rosalind McAlpine and Karel Kieslich summarise a recent systematic review which focuses on the rapid anti-suicidal ideation effect of ketamine.[read the full story...]
Can ketamine metabolites and gamma power help predict clinical response for ‘treatment resistant depression’?
Anya Borissova summarises a recent randomised placebo-controlled trial that evaluated ketamine metabolites, clinical response, and gamma power for major depression.[read the full story...]
Turn on, or tune out? Is psilocybin assisted therapy close to becoming a first-line treatment for depression?
James Rucker and Sameer Jauhar summarise a recent RCT on the effectiveness of psilocybin assisted therapy versus escitalopram assisted therapy for major depressive disorder.[read the full story...]
Patients’ experience of ketamine treatment for depression: the ‘Ketamine and me’ project
In her debut blog, Harmony Jiang reviews a recent qualitative study exploring patients’ experience and response to ketamine treatment for depression.[read the full story...]
MDMA-assisted psychotherapy for alcohol use disorder: is it feasible?
Anya Borissova reviews a recent UK pilot study which suggests that MDMA-assisted psychotherapy is a feasible intervention to use in people with alcohol use disorder. Now we need randomised trials that can reliably measure safety and effectiveness.[read the full story...]
Can psilocybin-assisted psychotherapy relieve existential crises in cancer patients?
Pascal Immanuel Michael reviews a randomised controlled trial examining long-term outcomes of psilocybin-assisted psychotherapy for existential distress in patients with cancer.[read the full story...]
Psilocybin for treatment-resistant depression: what are the effects on brain activity?
Anya Borissova summarises the therapeutic mechanisms of psilocybin in treatment-resistant depression and changes noticed in the amygdala and prefrontal cortex during emotional processing.[read the full story...]
MDMA-assisted psychotherapy for PTSD: moving towards post-traumatic growth?
Aster Daniel summarises a recent study exploring post-traumatic growth after MDMA-assisted psychotherapy for PTSD (post-traumatic stress disorder).[read the full story...]